Skip To The Main Content

New Trends, New Challenges for BET


Endotoxin testing for pharmaceutical production processes has seen a number of advances in recent years, among them discovery of recombinant Factor C (rFC) and development of the monocyte activation test (MAT). At the same time, data integrity has become an issue for various test modes.

You need to Login to view the full article. Please Login. Not a Member? Join today!

PDA Members Save Substantially